| NCT ID | NCT07872384 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 192 participants |
| Start Date | 2026-10-01 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 192 participants in total. It began in 2026-10-01 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study will evaluate the feasibility of a supplemental mobility intervention, the Safe Transfers And Mobility Program (STAMP). This program will be implemented in patients admitted to skilled nursing facilities (SNFs) following hospitalization. STAMP will be administered by a mobility aide who will support patients in increasing physical activity through walking and transfers outside of structured rehabilitation. Participants will either receive high-intensity rehabilitation (HIR) or usual care rehabilitation, combined with STAMP. The two main aims are: 1) determine the feasibility, acceptability, and safety of STAMP, and 2) evaluate the feasibility and variability of patient physical function outcome measures. The study will provide preliminary data on program delivery and safety to inform the design of a larger trial aimed at identifying the most effective strategies to optimize functional recovery in SNFs.
Eligibility Criteria
Inclusion Criteria: * At least 50 years old * Admitted to SNF from the hospital * Ambulatory at admission with minimal assistance or less Exclusion Criteria: * Contraindications to high-intensity resistance training (per American College of Sports Medicine Exercise Testing and Prescription) * Neurological diagnosis (e.g., cerebral vascular accident, multiple sclerosis, Parkinson's disease, traumatic brain injury) * Lower extremity weight-bearing precautions that require greater than minimal assistance with ambulation * Subsequent SNF admission
Contact & Investigator
Jennifer Stevens-Lapsley, PT, PhD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT07872384 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07872384 currently recruiting?
Yes, NCT07872384 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Colorado, Denver to inquire about joining.
Where is the NCT07872384 trial being conducted?
This trial is being conducted at Aurora, United States, Frisco, United States.
Who is sponsoring the NCT07872384 clinical trial?
NCT07872384 is sponsored by University of Colorado, Denver. The principal investigator is Jennifer Stevens-Lapsley, PT, PhD at University of Colorado, Denver. The trial plans to enroll 192 participants.